TAB-032

antibody from Creative Biolabs

Targeting: CD52 CDW52, EDDM5, HE5

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Immunoprecipitation (Recommended by provider)

Flow cytometry (Recommended by provider)

Blocking/Neutralizing (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

TAB-032

Provider

Creative Biolabs

Product name

Anti-Human CD52 Therapeutic Antibody (Campath, MabCampath)

Antibody type

Other

Description

Recombinant monoclonal antibodyto Human CD52. Alemtuzumab (marketed as Campath, MabCampath or Campath-1H and currently under further development as Lemtrada) is a monoclonal antibody used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma. It is also used in some conditioning regimens for bone marrow transplantation, kidney transplantation and Islet cell transplantation. Alemtuzumab binds to CD52, a protein present on the surface of mature lymphocytes, but not on the stem cells from which these lymphocytes are derived. After treatment with alemtuzumab, these CD52-bearing lymphocytes are targeted for destruction.Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.

Reactivity

Human

Host

Rat

Isotype

IgG

Vial size

1  mg

Storage

Store it under sterile conditions at -20° C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage.

Handling

The antibody solution should be gently mixed before use.